Cannabidiol Patent Expiration
Cannabidiol is Used for reducing convulsive seizure frequency in patients with Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. It was first introduced by Jazz Pharmaceuticals Research Uk Ltd
Cannabidiol Patents
Given below is the list of patents protecting Cannabidiol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Epidiolex | US11160795 | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus | Mar 01, 2041 | Jazz Pharms Res |
| Epidiolex | US11406623 | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus | Mar 01, 2041 | Jazz Pharms Res |
| Epidiolex | US11207292 | Cannabidiol preparations and its uses | Apr 26, 2039 | Jazz Pharms Res |
| Epidiolex | US11865102 | Cannabidiol preparations and its uses | Apr 26, 2039 | Jazz Pharms Res |
| Epidiolex | US10918608 | Use of cannabidiol in the treatment of epilepsy | Oct 13, 2035 | Jazz Pharms Res |
| Epidiolex | US11065209 | Use of cannabidiol in the treatment of epilepsy | Oct 13, 2035 | Jazz Pharms Res |
| Epidiolex | US11096905 | Use of cannabinoids in the treatment of epilepsy | Oct 13, 2035 | Jazz Pharms Res |
| Epidiolex | US11400055 | Use of cannabidiol in the treatment of epilepsy | Oct 13, 2035 | Jazz Pharms Res |
| Epidiolex | US10092525 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US10111840 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US10137095 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US10603288 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US10709671 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US10709673 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US10709674 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US10849860 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US10966939 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US11154516 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US11311498 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US11357741 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US11446258 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US11633369 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US11701330 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US11766411 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US11963937 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US12064399 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US9949937 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US9956183 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US9956184 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US9956185 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US9956186 | Use of cannabinoids in the treatment of epilepsy | Jun 17, 2035 | Jazz Pharms Res |
| Epidiolex | US10195159 | Processes and apparatus for extraction of active substances and enriched extracts from natural products |
May 07, 2022
(Expired) | Jazz Pharms Res |
Cannabidiol's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List